Filing Details

Accession Number:
0000899243-19-024045
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-23 15:51:46
Reporting Period:
2019-09-20
Accepted Time:
2019-09-23 15:51:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1641348 Omega Fund V Gp Manager, Ltd. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
1641354 Omega Fund V, L.p. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
1641355 Omega Fund V Gp, L.p. 888 Boylston Street, Suite 1111
Boston MA 02199
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-20 183,607 $21.96 6,553,416 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $22.19 per share, inclusive.
  2. The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.
  3. After completing the transactions reported above, none of the reporting persons, directly or indirectly, hold 10% or more of the issuer's outstanding Common Stock.